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Introduction: We aimed to assess any factors associated with dysplasia regression and with HPV clearance in a cohort of HIV
patients, with particular focus on cART and gender.
Methods: Asymptomatic HIV patients of the San Paolo Infectious Disease (SPID) cohort who underwent anoscopy/
gynaecological evaluation were enrolled. Anal/cervical brushing were analyzed for: HPV-PCR detection/genotyping (HR-HPV),
cytologic abnormalities (Bethesda System 2001: LSIL-HSIL). Demographics and HIV-related parameters were evaluated at
baseline. Activated CD8/CD38 lymphocytes were measured (flow citometry). Patients were examined at baseline (T0) and
at 1218 months visit (T1). HPV clearance was defined as negativisation of HPV at T1; SIL regression (SIL-R) and progression (SIL-
P) were defined as change from HSIL/LSIL to a lower-grade/absence of dysplasia and as change from absence of HSIL/LSIL to a
higher-grade dysplasia at T1, respectively. Mann Whitney test, Chi-square test and multivariate logistic regression were used.
Results: A total of 189 patients were examined, 60 (32%) were women. One hundred fifty patients (79%) were HPV, 113 (75%)
harboured HR-HPV; 103 (68%) showed LSIL/HSIL at T0 (32% of women and 65% of men) (all were HPV-positive). No differences
in demographics and HIV-related markers were found between patients with SIL-P (33, 41%) and patients with SIL-R (47, 59%).
HPV patients who cleared HPV (28, 18%) were found to be more frequently female, heterosexual infected, more frequently on
cART and with lower Log10 HIV-RNA and lower levels of CD8/CD38 % compared with HPV persistence group (Table 1).
No differences in PI exposure were found between the two groups (p.08). Interestingly, also when only HR-HPV were
considered, clearance was associated with exposure to cART (naı¨ve 4%, vs cART 86%, p.048). In multivariate analysis,
heterosexuals (AOR 5.123, 95% CI 1.517.5 vs homosexuals) were independently associated to HPV clearance, whereas CD8/
CD38% (AOR 0.44, 95% CI 0.651.01 for each % more) were predictive of HPV persistence.
Conclusions: Close follow-up of HPV and SIL should be promoted particularly in men and in untreated individuals. We cannot
exclude behavioural variables linked to risky sex and reinfection.
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Table 1. Characteristics of study population according to HPV clearance
Characteristics of Study Population Patients that cleared HPV (n28) Patients that remain HPV (n122) p
Female Sex 11 (39%) 19 (15%) 0.05
Heterosexual epidemiology 16 (57%) 29 (23%) 0.001
Log10 HIV-RNA* 1.77 (1.591.77) 1.77 (1.594.16) 0.038
cART 28 (100%) 122 (81%) 0.015
CD8/CD38%* 1 (12.7) 2 (16) 0.001
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